U.S. Supreme Court Declines J&J Appeal of $70M Risperdal Verdict
Johnson & Johnson is out of options after the U.S. Supreme Court declined to hear the pharmaceutical company’s appeal of a $70 million Risperdal verdict. In the cases of Yount vs. Janssen Pharmaceuticals, the 2019 Superior Court of Pennsylvania ruling stands. Yount’s doctor prescribed Risperdal off-label to address behavioral problems associated with autism when he […]
PA Supreme Court Upholds $70 Million Risperdal Verdict
The Pennsylvania Supreme Court has denied Johnson & Johnson’s request to overturn the $70 million Risperdal verdict upheld by a Superior court panel of judges last year. The case, A.Y. v. Janssen Pharmaceuticals, will now be remanded back to the PA Court of Common Pleas for a second trial to reconsider punitive damages. “We are […]
